BIOMAT Database Logo BIOMAT Database Logo

Omeprazole as adjunct to enzyme replacement in severe pancreatic insufficiency. 1986

C B Lamers, and J B Jansen

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009853 Omeprazole A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. H 168-68,Omeprazole Magnesium,Omeprazole Sodium,Prilosec,H 168 68,H 16868,Magnesium, Omeprazole,Sodium, Omeprazole
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D010188 Exocrine Pancreatic Insufficiency A malabsorption condition resulting from greater than 10% reduction in the secretion of pancreatic digestive enzymes (LIPASE; PROTEASES; and AMYLASE) by the EXOCRINE PANCREAS into the DUODENUM. This condition is often associated with CYSTIC FIBROSIS and with chronic PANCREATITIS. Pancreatic Insufficiency,Exocrine Pancreatic Insufficiencies,Insufficiencies, Exocrine Pancreatic,Insufficiencies, Pancreatic,Insufficiency, Exocrine Pancreatic,Insufficiency, Pancreatic,Pancreatic Insufficiencies,Pancreatic Insufficiencies, Exocrine,Pancreatic Insufficiency, Exocrine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C B Lamers, and J B Jansen
Pancreatic enzyme replacement therapy during pancreatic insufficiency.
June 2014, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition,
C B Lamers, and J B Jansen
Exocrine insufficiency and pancreatic enzyme replacement therapy in pancreatic cancer.
June 2010, Clinical oncology (Royal College of Radiologists (Great Britain)),
C B Lamers, and J B Jansen
Pancreatic enzyme replacement therapy: exocrine pancreatic insufficiency after gastrointestinal surgery.
December 2009, HPB : the official journal of the International Hepato Pancreato Biliary Association,
C B Lamers, and J B Jansen
Ranitidine compared with the dimethylprostaglandin E2 analogue enprostil as adjunct to pancreatic enzyme replacement in adult cystic fibrosis.
January 1990, Scandinavian journal of gastroenterology. Supplement,
C B Lamers, and J B Jansen
Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency.
April 1973, The New England journal of medicine,
C B Lamers, and J B Jansen
Enzyme replacement therapy for pancreatic insufficiency: present and future.
January 2011, Clinical and experimental gastroenterology,
C B Lamers, and J B Jansen
Comparative effects of adjuvant cimetidine and omeprazole during pancreatic enzyme replacement therapy.
May 1994, Digestive diseases and sciences,
C B Lamers, and J B Jansen
Response to long-term enzyme replacement treatment in dogs with exocrine pancreatic insufficiency.
July 1998, Journal of the American Veterinary Medical Association,
C B Lamers, and J B Jansen
The use of a synthetic prostaglandin E1 analogue (misoprostol) as an adjunct to pancreatic enzyme replacement in cystic fibrosis.
January 1988, Scandinavian journal of gastroenterology. Supplement,
C B Lamers, and J B Jansen
Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.
September 2014, World journal of gastroenterology,
Copied contents to your clipboard!